Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.49 |
| ▸ | MMP2 | P08253 | 5/20 | 0.46 |
| ▸ | MMP3 | P08254 | 5/20 | 0.46 |
| ▸ | MMP1 | P03956 | 3/20 | 0.46 |
| ▸ | MMP7 | P09237 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 4/20 | 0.46 |
| ▸ | PPARD | Q03181 | 4/20 | 0.46 |
| ▸ | PPARA | Q07869 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
| ▸ | TLR2 | O60603 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | FABP4 | P15090 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1358696 | 1.00 | GPR84 (0.50) | GPR84FFAR4FFAR1MMP2MMP3 | |
| SCHEMBL28429886 | 0.93 | GPR84 (0.56) | GPR84FFAR4FFAR1PPARGPPARD | |
| SCHEMBL28429888 | 0.93 | GPR84 (0.56) | GPR84FFAR4FFAR1PPARGPPARD | |
| SCHEMBL1259309 | 0.93 | GPR84 (0.56) | GPR84FFAR4FFAR1PPARGPPARD | |
| SCHEMBL1358131 | 0.93 | GPR84 (0.56) | GPR84FFAR4FFAR1PPARGPPARD | |
| SCHEMBL3782955 | 0.93 | GPR84 (0.56) | GPR84FFAR4FFAR1PPARGPPARD | |
| SCHEMBL1259306 | 0.93 | GPR84 (0.56) | GPR84FFAR4FFAR1PPARGPPARD | |
| SCHEMBL1358023 | 0.93 | GPR84 (0.56) | GPR84FFAR4FFAR1PPARGPPARD | |
| SCHEMBL3782952 | 0.93 | GPR84 (0.56) | GPR84FFAR4FFAR1PPARGPPARD | |
| SCHEMBL1358025 | 0.93 | GPR84 (0.56) | GPR84FFAR4FFAR1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5654289-A | HAVING GLUCOSAMINE STRUCTURE AND FREE HYDROXYL GROUPS, ALSO LINKED TO A PHOSPHATE GROUP AND SUBSTITUTED ALKYL GROUPS, WITH MITOGENIC, ANTITUMOR AND ANTIVIRAL ACTIVITY | SUNTORY LIMITED (JP) | 1997-08-05 | — | — | US | claimed |
| EP-0668289-A1 | NOVEL DISACCHARIDE DERIVATIVE | SUNTORY LIMITED (JP) | 1995-08-23 | — | — | EP | claimed |
| US-9309276-B2 | Synthetic lipid A derivative | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2016-04-12 | — | — | US | disclosed |
| US-20140011987-A1 | Synthetic Lipid A Derivative | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2014-01-09 | — | — | US | disclosed |
| US-8563523-B2 | Synthetic lipid A derivative | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2013-10-22 | — | — | US | disclosed |
| US-20110280893-A9 | SYNTHETIC LIPID A DERIVATIVE | UNIVERSITY OF GEORGIA RESEACH FOUNDATION, INC (US) | 2011-11-17 | — | — | US | disclosed |
| US-20100221269-A1 | SYNTHETIC LIPID A DERIVATIVE | UNIVERSITY OF GEORGIA RESEACH FOUNDATION, INC (US) | 2010-09-02 | — | — | US | disclosed |
| US-5654289-A | HAVING GLUCOSAMINE STRUCTURE AND FREE HYDROXYL GROUPS, ALSO LINKED TO A PHOSPHATE GROUP AND SUBSTITUTED ALKYL GROUPS, WITH MITOGENIC, ANTITUMOR AND ANTIVIRAL ACTIVITY | SUNTORY LIMITED (JP) | 1997-08-05 | — | — | US | disclosed |
| EP-0668289-A1 | NOVEL DISACCHARIDE DERIVATIVE | SUNTORY LIMITED (JP) | 1995-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140011987-A1 | Synthetic Lipid A Derivative | DDOST, STT3A, UGCG | GPR84 925/4885FFAR4 110/4885FFAR1 136/4885 |
| US-20110280893-A9 | SYNTHETIC LIPID A DERIVATIVE | DDOST, STT3A, UGCG | GPR84 925/4885FFAR4 110/4885FFAR1 136/4885 |
| US-20100221269-A1 | SYNTHETIC LIPID A DERIVATIVE | DDOST, STT3A, UGCG | GPR84 925/4885FFAR4 110/4885FFAR1 136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.